Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial. - Wikidata - wikimedia - TriplyDB

Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial.

Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial.

http://www.wikidata.org/entity/Q37663361

about

Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial.

http://www.wikidata.org/entity/Q37663361

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@en

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@nl

type

label

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@en

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@nl

prefLabel

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@en

Evaluation of Aggregometery Pa ...... d Double Blind Clinical Trial.

@nl

P1433

Q37663361-9439ACF2-C8FF-4E95-B8EA-5FB601B9BB0F

P1476

Q37663361-0BC6116C-0F30-45F6-9AA9-A2CD58E4E467

P2093

Q37663361-194E8C87-7939-4DE0-AD73-5A220BB27348

Q37663361-1D989B5A-1262-496C-A3D4-756B4357302C

Q37663361-56DDED8F-FB12-431F-8CDF-F82AA5D9B603

Q37663361-92129E89-C0FA-40A2-98B6-F04780AB8983

Q37663361-BCDFB1DB-7D56-40DB-8F50-62112AB8C6CB

Q37663361-F9E31931-FD3F-4171-9BEF-F0A5F64A49D0

P2860

Q37663361-13F7F7FD-02CB-44C9-8E3E-7E69EB069E72

Q37663361-3361A92A-C93E-442B-9CEF-A99CD95AD173

Q37663361-40A12042-B197-4F71-8D8B-FFF0323719DB

Q37663361-48FF6D01-23CC-423A-8F5A-6A7A1FD9B86C

Q37663361-621046E2-BBBE-42AD-96AA-EE640DD84D8D

Q37663361-770B8E4D-E5A4-4C92-AB22-0FC017A8F6DB

Q37663361-8D450A3A-EFD7-4C04-8812-49CF34CF1D45

Q37663361-9703332B-3CB6-414D-A019-FE727C04ABCB

Q37663361-A098867D-094D-4636-B89E-AD14AA86C384

Q37663361-B3C965E9-75AA-4DDB-8A82-4622907152C0

P304

Q37663361-80413ABB-D5F3-452E-AE24-4ECDFDE8B323

P31

Q37663361-F6F107B5-7B8D-4C0C-92E8-872684B6115F

P356

Q37663361-E575C482-CEEB-48B3-8211-7C556105FC01

P433

Q37663361-64A80CED-E824-4F3D-A7CF-550549956912

P478

Q37663361-93FF6BCE-A7A6-4061-90E3-82DF6D312222

P50

Q37663361-3B88E14C-0919-4ED5-A1B5-85A53F33EC3A

P577

Q37663361-4EBA1C06-1297-4638-B007-D5DC4F07CC8D

P5875

Q37663361-C6433C4C-2A05-4F63-B22F-DF9BBC7DC537

P698

Q37663361-50B78AA2-CDB9-4E73-80DF-A548957B1BF0

P921

Q37663361-D70D63F7-399F-495B-9CFC-5F31FA657816

P932

Q37663361-D7904BFC-B361-4E53-B9A2-A9D9E1C7A518

P356

P1433

Iranian Red Crescent medical journal

P1476

Evaluation of Aggregometery Pa ...... ed Double Blind Clinical Trial

@en

P2093

Bita Najafian

http://www.w3.org/2001/XMLSchema#string

Davoud Kazemisaleh

http://www.w3.org/2001/XMLSchema#string

Majid Shohrati

http://www.w3.org/2001/XMLSchema#string

Maryam Moshkani

http://www.w3.org/2001/XMLSchema#string

Minoo Ahmadinejad

http://www.w3.org/2001/XMLSchema#string

Nastaran Najafian

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial

The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events

The role of clopidogrel in the management of ischemic heart disease

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Clinical epidemiology of acute myocardial infarction.

Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome Project.

Differences between men and women in terms of clinical features of ST-segment elevation acute myocardial infarction.

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.

P304

e15277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/IRCMJ.15277

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261521613

http://www.w3.org/2001/XMLSchema#string

P698

24719748

http://www.w3.org/2001/XMLSchema#string

P921

P932

3965881

http://www.w3.org/2001/XMLSchema#string